Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız:
http://hdl.handle.net/11452/28221
Tüm üstveri kaydı
Dublin Core Alanı | Değer | Dil |
---|---|---|
dc.date.accessioned | 2022-08-17T07:26:44Z | - |
dc.date.available | 2022-08-17T07:26:44Z | - |
dc.date.issued | 2015-12 | - |
dc.identifier.citation | Yılmaz, M. S. (2015). "The role of centrally injected nesfatin-1 on cardiovascular regulation in normotensive and hypotensive rats". Autonomic Neuroscience: Basic and Clinical, 193, 63-68. | en_US |
dc.identifier.issn | 1566-0702 | - |
dc.identifier.issn | 1872-7484 | - |
dc.identifier.uri | https://doi.org/10.1016/j.autneu.2015.07.009 | - |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S1566070215300126 | - |
dc.identifier.uri | http://hdl.handle.net/11452/28221 | - |
dc.description.abstract | This study investigated the cardiovascular effects of nesfatin-1 in normotensive rats and animals subjected to hypotensive hemorrhage. Hemorrhagic hypotension was induced by withdrawal 2 mL blood/100 g body weight over a period of 10 min. Acute hemorrhage led to a severe and long-lasting decrease in mean arterial pressure (MAP) and heart rate (HR). Intracerebroventricularly (i.c.v.) administered nesfatin-1 (100 pmol) increased MAP in both normotensive and hemorrhaged rats. Nesfatin-1 also caused bradycardia in normotensive and tachycardia in hemorrhaged rats. Centrally injected nesfatin-1 (100 pmol, i.c.v.) also increased plasma catecholamine, vasopressin and renin concentrations in control animals and potentiated the rise in all three cardiovascular mediators produced by hemorrhage. These findings indicate that centrally administered nesfatin-1 causes a pressor response in conscious normotensive and hemorrhaged rats and suggest that enhanced sympathetic activity and elevated vasopressin and renin concentrations mediate the cardiovascular effects of the peptide. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Neurosciences & neurology | en_US |
dc.subject | Nesfatin-1 | en_US |
dc.subject | Mean arterial pressure | en_US |
dc.subject | Heart rate | en_US |
dc.subject | Hemorrhagic shock | en_US |
dc.subject | Catecholamine | en_US |
dc.subject | Vasopressin | en_US |
dc.subject | Renin | en_US |
dc.subject | Paraventricular nucleus | en_US |
dc.subject | Brain | en_US |
dc.subject | Neuroendocrine | en_US |
dc.subject | Neurons | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Blood pressure | en_US |
dc.subject.mesh | Bradycardia | en_US |
dc.subject.mesh | Calcium-binding proteins | en_US |
dc.subject.mesh | Catecholamines | en_US |
dc.subject.mesh | Central nervous system agents | en_US |
dc.subject.mesh | Disease models, animal | en_US |
dc.subject.mesh | DNA-binding proteins | en_US |
dc.subject.mesh | Heart rate | en_US |
dc.subject.mesh | Hemorrhage | en_US |
dc.subject.mesh | Hypotension | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Nerve tissue proteins | en_US |
dc.subject.mesh | Rats | en_US |
dc.subject.mesh | Sprague-dawley | en_US |
dc.subject.mesh | Renin | en_US |
dc.subject.mesh | Vasopressins | en_US |
dc.title | The role of centrally injected nesfatin-1 on cardiovascular regulation in normotensive and hypotensive rats | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000366077800010 | tr_TR |
dc.identifier.scopus | 2-s2.0-84947491740 | tr_TR |
dc.relation.tubitak | 1919B011302992 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Farmakoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Veterinerlik Fakültesi/Fizyoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Veterinerlik Fakültesi/Biyokimya Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Veterinerlik Fakültesi/Anatomi Anabilim Dalı. | tr_TR |
dc.relation.bap | BAP | tr_TR |
dc.contributor.orcid | 0000-0001-9496-1475 | tr_TR |
dc.contributor.orcid | 0000-0002-9534-736X | tr_TR |
dc.contributor.orcid | 0000-0002-1413-3651 | tr_TR |
dc.contributor.orcid | 0000-0001-7052-1694 | tr_TR |
dc.contributor.orcid | 0000-0001-6342-0094 | tr_TR |
dc.contributor.orcid | 0000-0002-5600-8162 | tr_TR |
dc.identifier.startpage | 63 | tr_TR |
dc.identifier.endpage | 68 | tr_TR |
dc.identifier.volume | 193 | tr_TR |
dc.relation.journal | Autonomic Neuroscience: Basic and Clinical | en_US |
dc.contributor.buuauthor | Yılmaz, Mustafa Sertaç | - |
dc.contributor.buuauthor | Altınbaş, Burçin | - |
dc.contributor.buuauthor | Güvenç, Gökçen | - |
dc.contributor.buuauthor | Erkan, Leman Gizem | - |
dc.contributor.buuauthor | Avşar, Özge | - |
dc.contributor.buuauthor | Savcı, Vahide | - |
dc.contributor.buuauthor | Küçükşen, Duygu Udum | - |
dc.contributor.buuauthor | Arıcan, İlker | - |
dc.contributor.buuauthor | Yalçın, Murat | - |
dc.contributor.researcherid | AAH-1571-2021 | tr_TR |
dc.contributor.researcherid | AAR-6815-2021 | tr_TR |
dc.contributor.researcherid | AAH-5167-2021 | tr_TR |
dc.contributor.researcherid | AAG-7518-2021 | tr_TR |
dc.contributor.researcherid | AAG-6956-2021 | tr_TR |
dc.identifier.pubmed | 26254710 | tr_TR |
dc.subject.wos | Neurosciences | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q4 | en_US |
dc.contributor.scopusid | 8895544100 | tr_TR |
dc.contributor.scopusid | 55356919300 | tr_TR |
dc.contributor.scopusid | 56529426800 | tr_TR |
dc.contributor.scopusid | 56529371200 | tr_TR |
dc.contributor.scopusid | 56764150800 | tr_TR |
dc.contributor.scopusid | 6603687024 | tr_TR |
dc.contributor.scopusid | 56764576200 | tr_TR |
dc.contributor.scopusid | 14055524200 | tr_TR |
dc.contributor.scopusid | 57192959734 | tr_TR |
dc.subject.scopus | Nucleobindin; Pyroglutamyl-Histidyl-Glycine; DNA-Binding Proteins | en_US |
dc.subject.emtree | Catecholamine | en_US |
dc.subject.emtree | Nesfatin 1 | en_US |
dc.subject.emtree | Neuropeptide | en_US |
dc.subject.emtree | Renin | en_US |
dc.subject.emtree | Unclassified drug | en_US |
dc.subject.emtree | Vasopressin | en_US |
dc.subject.emtree | Calcium binding proteins | en_US |
dc.subject.emtree | Central nervous system agents | en_US |
dc.subject.emtree | DNA binding proteins | en_US |
dc.subject.emtree | Nerve protein | en_US |
dc.subject.emtree | Nucleobindin | en_US |
dc.subject.emtree | Renin | en_US |
dc.subject.emtree | Vasopressin derivative | en_US |
dc.subject.emtree | Animal experiment | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Bradycardia | en_US |
dc.subject.emtree | Cardiovascular effect | en_US |
dc.subject.emtree | Catecholamine blood level | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Heart rate | en_US |
dc.subject.emtree | Hemorrhagic hypotension | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Mean arterial pressure | en_US |
dc.subject.emtree | Nonhuman | en_US |
dc.subject.emtree | Pressor response | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Rat | en_US |
dc.subject.emtree | Tachycardia | en_US |
dc.subject.emtree | Vasopressin blood level | en_US |
dc.subject.emtree | Animal | en_US |
dc.subject.emtree | Bleeding | en_US |
dc.subject.emtree | Blood | en_US |
dc.subject.emtree | Blood pressure | en_US |
dc.subject.emtree | Complication | en_US |
dc.subject.emtree | Disease model | en_US |
dc.subject.emtree | Drug effects | en_US |
dc.subject.emtree | Hypotension | en_US |
dc.subject.emtree | Pathophysiology | en_US |
dc.subject.emtree | Physiology | en_US |
dc.subject.emtree | Sprague Dawley rat | en_US |
Koleksiyonlarda Görünür: | PubMed Scopus Web of Science |
Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.
DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.